Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Ditsch

Showing results (111-120 of 207) with videos related to

Pageof 21
Sort By:
BMC Cancer|April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancerAnna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Geburtshilfe Und Frauenheilkunde|July 2, 2025
Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|March 16, 2026
Correction: Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Cancers|October 16, 2024
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)Natalia Krawczyk, Thorsten Kühn, Nina Ditsch, et al.
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.
Cancers|April 30, 2021
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized TrialsMaria Luisa Gasparri, Thorsten Kuehn, Ilary Ruscito, et al.
Archives of Gynecology and Obstetrics|May 27, 2023
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgeryNicole Pochert, Mariella Schneider, Melitta B Köpke, et al.
Journal of the National Cancer Institute|May 19, 2017
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer PatientsKerstin Hermelink, Markus Bühner, Philipp Sckopke, et al.
Geburtshilfe Und Frauenheilkunde|August 24, 2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in HealthcareVolkmar Müller, Peter A Fasching, Naiba Nabieva, et al.
Pageof 21

Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
BMC Cancer|April 18, 2018
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancerAnna Semmlinger, Viktoria von Schoenfeldt, Verena Wolf, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Geburtshilfe Und Frauenheilkunde|July 2, 2025
Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|March 16, 2026
Correction: Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Cancers|October 16, 2024
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)Natalia Krawczyk, Thorsten Kühn, Nina Ditsch, et al.
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.
Cancers|April 30, 2021
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized TrialsMaria Luisa Gasparri, Thorsten Kuehn, Ilary Ruscito, et al.
Archives of Gynecology and Obstetrics|May 27, 2023
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgeryNicole Pochert, Mariella Schneider, Melitta B Köpke, et al.
Journal of the National Cancer Institute|May 19, 2017
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer PatientsKerstin Hermelink, Markus Bühner, Philipp Sckopke, et al.
Geburtshilfe Und Frauenheilkunde|August 24, 2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in HealthcareVolkmar Müller, Peter A Fasching, Naiba Nabieva, et al.
Pageof 21